Author: Multibagger News

Katsunobu Kato Calls for Stimulus Package to Boost Domestic Investment and Regional Economies In a bold move to revitalize Japan’s economy, Katsunobu Kato, former health minister and candidate in the ruling party leadership race, has proposed compiling a stimulus package to fund spending aimed at boosting domestic investment and revitalizing regional economies. Kato emphasized the importance of doubling households’ income through wage hikes to drive a consumption-led recovery and propel Japan out of deflation. During a news conference announcing his candidacy in the Liberal Democratic Party’s leadership race on Sept. 27, Kato outlined his vision of redirecting companies’ reserves towards…

Stay informed with the most recent news on the devastating impact of Typhoon Yagi in northern Vietnam, as landslides and floods have claimed the lives of at least 58 people, with 40 others still missing. Find out more details here. HANOI (Multibagger) – Typhoon Yagi and the landslides and floods it triggered have killed at least 58 people and 40 others are missing in northern Vietnam, the disaster management agency said on Tuesday. Most of the victims were killed in landslides and flash floods, the agency said in a report, adding that nearly 750 people have been injured. The typhoon…

Travere Therapeutics, Inc. (NASDAQ:TVTX) recently made headlines with its Chief Medical Officer, Jula Inrig, selling shares in the company. This transaction, which took place on September 9, 2024, involved the sale of 2,191 shares at $11.52 per share, totaling over $25,000. The sale followed the vesting of performance restricted stock units (PSUs) granted to Inrig on January 31, 2023, which vested upon the FDA’s full approval of FILSPARI (sparsentan) in IgA Nephropathy on September 5, 2024. This sale was necessary to cover the tax withholding obligation associated with the settlement of the vested PSUs, as mandated by the company’s equity…

The Federal Reserve Keeping 50 Basis Point Rate Cut Option in Back Pocket, Analysts Say – Investing.com In a note ahead of the Fed’s Sept. 18 meeting, analysts at Capital Economics suggest that policymakers are likely to hold onto the 50 basis point rate cut option as the economic slowdown intensifies. While market bets on a 50 basis point rate cut at the upcoming FOMC meeting have slightly decreased, the possibility of larger cuts in subsequent meetings has increased, according to signals from Fed officials. Fed Governor Christopher Waller expressed willingness to support larger rate cuts if the data indicates…

Huawei’s Three-Way Foldable Phone: A Game-Changer in China’s Smartphone Market? By David Kirton SHENZHEN, China (Multibagger) – In a strategic move to solidify its dominance over Apple (NASDAQ: AAPL) in the world’s largest smartphone market, China’s Huawei Technologies unveiled its revolutionary three-way foldable phone on Tuesday. This innovative Z-shaped Mate XT aims to capture the growing enthusiasm for foldable smartphones in China, mere hours after Apple’s latest iPhone release. Huawei’s new Mate XT, showcased on its flagship e-commerce platforms a day before the official launch, has already amassed over 3.3 million pre-orders. This staggering figure highlights the immense interest in…

By Kirsty Needham World Bank President Ajay Banga recently concluded a whirlwind tour of 27 countries, from Peru to Tuvalu, where he emphasized the need for faster action and simplified processes in a world marked by increasing polarization. Speaking at the Lowy Institute in Sydney, Banga highlighted the challenges faced by nations around the globe and the urgent need for impactful solutions. During his visit to Tuvalu, Banga engaged with Pacific Islands leaders who expressed the need for expedited support from the World Bank. Small island states, in particular, are grappling with meeting the stringent requirements set by the global…

By Joshua McElwee DILI (Multibagger) – Pope Francis arrived on Monday in East Timor, a predominantly Catholic nation in Southeast Asia, for a three-day visit that will include an open-air celebration of Mass the Vatican says could draw more than half the population of 1.3 million. The 87-year-old pontiff is on an ambitious 12-day Asia-Pacific tour, his longest overseas journey yet. His trip to East Timor, one of two majority Catholic countries in Asia, is only the second such visit by a pope. Francis arrived from Papua New Guinea, where on Sunday he delivered medical supplies to a small town…

Insider Sale Alert: Travere Therapeutics CFO Sells Shares After FDA Approval Boost In a recent financial move, Christopher R. Cline, CFO of Travere Therapeutics, Inc. (NASDAQ:TVTX), sold 2,490 shares of company stock for over $28,000. This sale follows the FDA’s full approval of the company’s drug FILSPARI (sparsentan) for IgA Nephropathy, leading to vested PSUs for Mr. Cline. Insider sales like these can provide valuable insights into executive views on company valuation and future prospects. Travere Therapeutics, known for rare disease treatments, has seen positive developments post-FDA approval, with increased stock value and analyst ratings. Despite recent growth, caution is…

Asian Stocks Rise Following Wall Street Rebound; Chinese Economy Concerns Linger As the world’s top investment manager and financial market expert, I am here to provide you with the latest updates on the global stock market trends. Asian stocks have reversed early losses and are on the rise, following a strong rally on Wall Street. Despite this positive trend, concerns about the struggling Chinese economy continue to weigh on market sentiment. MSCI’s broadest index of Asia-Pacific shares outside Japan has seen a 0.2% increase after hitting a one-month low in the previous session. Wall Street experienced a significant rebound, with…

Insider Selling at Travere Therapeutics (NASDAQ:TVTX): CEO Dube Sells Shares Following FDA Approval In recent news, Travere Therapeutics, Inc. (NASDAQ:TVTX) saw its Chief Executive Officer, Eric M. Dube, sell 21,125 shares of common stock at an average price of $11.52, totaling approximately $243,360. The sale, which occurred on September 9, 2024, was part of a pre-arranged 10b5-1 trading plan to cover tax obligations related to the vesting of performance restricted stock units (PSUs). The PSUs vested following the FDA’s full approval of FILSPARI (sparsentan) for IgA Nephropathy treatment. Dube’s direct ownership in Travere Therapeutics now stands at 361,975 shares, down…